65162-749 : Rivastigmine 13.3 mg/24h Transdermal Patch


NDC: 65162-749
Labeler: Amneal Pharmaceuticals LLC
Product Type: Human Prescription Drug
Drug Name:  Rivastigmine
Dosage Form: Transdermal Patch
Application #: ANDA207308
Rev. Date: 


NDC Package Codes:

  • 65162-749-34: 30 PATCH IN 1 CARTON (65162‑749‑34) > 24 H IN 1 PATCH

Active Ingredients:

  • Rivastigmine

Dosage Strength:

  • 13.3 mg/24h

Pharmaceutical Classes:

  • Cholinesterase Inhibitor [EPC]
  • Cholinesterase Inhibitors [MoA]

Related Products:

Based on records with the same trade name.
  • 65162-825 Rivastigmine 4.6 mg/24h Transdermal Patch by Amneal Pharmaceuticals LLC
  • 65162-826 Rivastigmine 9.5 mg/24h Transdermal Patch by Amneal Pharmaceuticals LLC
  • 0378-9070 Rivastigmine 4.6 mg/24h Transdermal Patch by Mylan Pharmaceuticals Inc.
  • 0378-9071 Rivastigmine 9.5 mg/24h Transdermal Patch by Mylan Pharmaceuticals Inc.
  • 0378-9072 Rivastigmine 13.3 mg/24h Transdermal Patch by Mylan Pharmaceuticals Inc.
  • 0781-7304 Rivastigmine 4.6 mg/24h Transdermal Patch, Extended Release by Sandoz Inc
  • 0781-7309 Rivastigmine 9.5 mg/24h Transdermal Patch, Extended Release by Sandoz Inc
  • 0781-7313 Rivastigmine 13.3 mg/24h Transdermal Patch, Extended Release by Sandoz Inc
  • 16714-115 Rivastigmine 4.6 mg/24h Transdermal Patch, Extended Release by Northstar Rx LLC.
  • 16714-116 Rivastigmine 9.5 mg/24h Transdermal Patch, Extended Release by Northstar Rx LLC.
  • 16714-117 Rivastigmine 13.3 mg/24h Transdermal Patch, Extended Release by Northstar Rx LLC.
  • 51956-0001 Rivastigmine 4.6 mg/24h Transdermal Patch, Extended Release by Zydus Technologies Limited
  • 51956-0002 Rivastigmine 9.5 mg/24h Transdermal Patch, Extended Release by Zydus Technologies Limited
  • 51956-0003 Rivastigmine 13.3 mg/24h Transdermal Patch, Extended Release by Zydus Technologies Limited
  • 70710-1196 Rivastigmine 4.6 mg/24h Transdermal Patch, Extended Release by Zydus Pharmaceuticals (Usa) Inc.
  • 70710-1197 Rivastigmine 9.5 mg/24h Transdermal Patch, Extended Release by Zydus Pharmaceuticals (Usa) Inc.
  • 70710-1198 Rivastigmine 13.3 mg/24h Transdermal Patch, Extended Release by Zydus Pharmaceuticals (Usa) Inc.

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 65162-749 QR Code

< Prev: 65162-745Next: 65162-750 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.